Loading...

Categories

12 Asia Hyperglycemics Reports

APAC Insulin Market

Region Covered: Asia

Study Period: 2019 - 2029

Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee

Asia Pacific SGLT2 Inhibitors Market

Region Covered: Asia

Study Period: 2018 - 2029

Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand

Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb

APAC Biguanide Industry

Region Covered: Asia

Study Period: 2019 - 2029

Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand

Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis

APAC Meglitinide Industry

Region Covered: Asia

Study Period: 2018 - 2029

Countries Covered: Japan, China, South Korea, India, Australia, Malaysia, Indonesia, Philippines, Thailand

Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon

Insulin Market

Region Covered: Asia

Study Period: 2019 - 2029

Countries Covered: United States, Canada, France, Germany, Italy, Spain, United Kingdom, Russia, Mexico, Brazil, Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Pfizer Inc.

Biguanides Market

Region Covered: Asia

Study Period: 2018 - 2029

Countries Covered: United States, Canada, Germany, Spain, Italy, France, United Kingdom, Russia, Japan, China, Australia, India, South Korea, Malaysia, Indonesia, Thailand, Philippines, Vietnam, Brazil, Mexico, South Africa, Saudi Arabia, Oman, Egypt, Iran

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.

Meglitinides Market

Region Covered: Asia

Study Period: 2019- 2029

Countries Covered: United States, Canada, Germany, Spain, Italy, France, United Kingdom, Russia, Japan, China, Australia, India, South Korea, Malaysia, Indonesia, Thailand, Vietnam, Philippines, Brazil, Mexico, South Africa, Saudi Arabia, Oman, Egypt, Iran

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

Sulfonylureas Industry

Region Covered: Asia

Study Period: 2019- 2029

Countries Covered: United States, Canada, France, Germany, Italy, Spain, United Kingdom, Russia, Mexico, Brazil, Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

SGLT2 Inhibitors Market

Region Covered: Asia

Study Period: 2019 - 2029

Countries Covered: United States, Canada, France, Germany, Italy, Spain, United Kingdom, Russia, Mexico, Brazil, Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Basal Insulin (Long-Acting Insulin) Market

Region Covered: Asia

Study Period: 2019 - 2029

Countries Covered: United States, Canada, Germany, Spain, Italy, France, United Kingdom, Russia, Japan, China, Australia, India, South Korea, Malaysia, Indonesia, Thailand, Philippines, Vietnam, Brazil, Mexico, South Africa, Saudi Arabia, Oman, Egypt, Iran

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Fibrate Drugs Market

Region Covered: Asia

Study Period: 2019 - 2029

Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina

Major Players: Abbott, Sanofi , Mylan Inc, Lupin, Aurobindo Pharma

Glargine Insulin Market

Region Covered: Asia

Study Period: 2018 - 2029

Countries Covered: United States, Canada, France, Germany, Italy, Spain, United Kingdom, Russia, Mexico, Brazil, Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Filter Reports

By Countries